Pulmatrix, Inc. — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2020-08-28

Reporting Person: GILLIS STEVEN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-28	Stock Option (Right to Buy)	$118.00	D	1771	Disposed	2025-06-16	Common Stock (1771)	Direct
2020-08-28	Stock Option (Right to Buy)	$118.00	A	1771	Acquired	2021-09-01	Common Stock (1771)	Direct
2020-08-28	Stock Option (Right to Buy)	$110.00	D	111	Disposed	2025-06-24	Common Stock (111)	Direct
2020-08-28	Stock Option (Right to Buy)	$110.00	A	111	Acquired	2021-09-01	Common Stock (111)	Direct
2020-08-28	Stock Option (Right to Buy)	$28.00	D	880	Disposed	2026-02-03	Common Stock (880)	Direct
2020-08-28	Stock Option (Right to Buy)	$28.00	A	880	Acquired	2021-09-01	Common Stock (880)	Direct
2020-08-28	Stock Option (Right to Buy)	$27.80	D	440	Disposed	2027-03-20	Common Stock (440)	Direct
2020-08-28	Stock Option (Right to Buy)	$27.80	A	440	Acquired	2021-09-01	Common Stock (440)	Direct
2020-08-28	Stock Option (Right to Buy)	$4.68	D	12400	Disposed	2028-06-05	Common Stock (12400)	Direct
2020-08-28	Stock Option (Right to Buy)	$4.68	A	12400	Acquired	2021-09-01	Common Stock (12400)	Direct
2020-08-28	Stock Option (Right to Buy)	$1.06	D	15000	Disposed	2029-05-16	Common Stock (15000)	Direct
2020-08-28	Stock Option (Right to Buy)	$1.06	A	15000	Acquired	2021-09-01	Common Stock (15000)	Direct
2020-08-28	Stock Option (Right to Buy)	$1.54	D	15000	Disposed	2030-01-09	Common Stock (15000)	Direct
2020-08-28	Stock Option (Right to Buy)	$1.54	A	15000	Acquired	2021-09-01	Common Stock (15000)	Direct
2020-08-28	Stock Option (Right to Buy)	$1.28	D	10000	Disposed	2030-04-02	Common Stock (10000)	Direct
2020-08-28	Stock Option (Right to Buy)	$1.28	A	10000	Acquired	2021-09-01	Common Stock (10000)	Direct

Footnotes

F1: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 16, 2015 and vested 100% on June 16, 2020. The post-termination exercise period was extended to September 1, 2021.

F2: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 24, 2015 and vested 100% on June 16, 2020. The post-termination exercise period was extended to September 1, 2021.

F3: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on February 3, 2016 and vested 100% on February 3, 2020. The post-termination exercise period was extended to September 1, 2021.

F4: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on March 20, 2017 and provided for 25% vesting on March 20, 2018 and the remaining 75% to vest in thirty-six (36) equal monthly installments with 2.083% for each of the next thirty-six (36) months that follow March 20, 2018. Vesting was accelerated for 63 options that otherwise would not have become vested due to the reporting person's resignation. The post-termination exercise period was extended to September 1, 2021.

F5: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 5, 2018 and provided for 25% vesting on June 5, 2018 and the remaining 75% to vest in thirty-six (36) equal monthly installments with 2.083% for each of the next thirty-six (36) months that follow June 5, 2018. Vesting was accelerated for 2,581 options that otherwise would not have become vested due to the reporting person's resignation. The post-termination exercise period was extended to September 1, 2021.

F6: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 16, 2019 and provided for vesting in forty-eight (48) equal monthly installments on the 16th day of each month, with the first tranche vesting on June 16, 2019. Vesting was accelerated for 10,313 options that otherwise would not have become vested due to the reporting person's resignation. The post-termination exercise period was extended to September 1, 2021.

F7: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 9, 2020 and provided for vesting in forty-eight (48) equal monthly installments beginning on the first monthly anniversary of the date of grant. Vesting was accelerated for 12,813 options that otherwise would not have become vested due to the reporting person's resignation. The post-termination exercise period was extended to September 1, 2021.

F8: The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on April 2, 2020 and provided for vesting in forty-eight (48) equal monthly installments beginning on the first monthly anniversary of the date of grant. Vesting was accelerated for 9,167 options that otherwise would not have become vested due to the reporting person's resignation. The post-termination exercise period was extended to September 1, 2021.

F9: The securities and exercise prices shown have been adjusted from the time of grant to reflect the Issuer's 1-for-10 reverse stock split on February 3, 2019.